Literature DB >> 27023364

A Case-Control Study Indicates that no Association Exists Between Polymorphisms of IL-33 and IL-1RL1 and Preeclampsia.

Xiaoyan Ren, Mingzhen Guo, Caili Liu, Tao Huang, Qiang Li, Mengmeng Han, Weiqing Song, Xiuming Tang, Shiguo Liu.   

Abstract

BACKGROUND/AIMS: Preeclampsia (PE) is a systemic inflammatory response syndrome involving varieties of cytokines, and previous studies have shown that IL-33 and its receptor IL-1RL1 play pivotal roles in the development of it. As a polygenetic hereditary disease, it is necessary to study the gene analysis for PE. Therefore, the present study was to determine whether IL-33 rs3939286 and IL-1RL1 rs13015714 associated with susceptibility to PE in Chinese Han women.
METHODS: 1,031 PE patients and 1,298 controls were enrolled and the genotyping for rs3939286 in IL-33 and rs13015714 in IL-1RL1 was performed by TaqMan allelic discrimination real-time PCR. Hardy-Weinberg equilibrium (HWE) was examined to ensure the group representativeness and Pearson's chi-square test was used to compare the differences in genetic distributions between the two groups.
RESULTS: No significant differences in genotypic and allelic frequencies of the two polymorphisms loci were observed between cases and controls. There were also no significant differences in genetic distributions between mild/severe and early/late-onset PE and control groups.
CONCLUSION: Although our data suggested that the polymorphisms of IL-33 rs3939286 and IL-1RL1 rs13015714 might not be critical risk factors for PE in Chinese Han women, the results need to be validated in different nations.
© 2016 The Author(s) Published by S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27023364     DOI: 10.1159/000443083

Source DB:  PubMed          Journal:  Cell Physiol Biochem        ISSN: 1015-8987


  1 in total

1.  Screening of mitochondrial mutations in Saudi women diagnosed with gestational diabetes mellitus: A non-replicative case-control study.

Authors:  Khalid Khalaf Alharbi; Abdullah Sulaiman Alsaikhan; Amal F Alshammary; Malak Mohammed Al-Hakeem; Imran Ali Khan
Journal:  Saudi J Biol Sci       Date:  2021-09-06       Impact factor: 4.219

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.